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Abstract.  We have previously shown that the neural 
adhesion molecules L1 and NCAM interact with each 
other to form a complex which binds more avidly to 
L1 than L1 to L1 alone (Kadmon,  G., A.  Kowitz, P. 
Altevogt, and M.  Schachner.  1990a. J.  Cell Biol. 
110:193-208).  This cis-association between L1 and 
NCAM is carbohydrate-dependent (Kadmon,  G., A. 
Kowitz, P. Altevogt, and M.  Schachner.  1990b. J.  Cell 
Biol.  110:209-218).  In the present study, we report 
that L1 and NCAM bind to each other via oligo- 
mannosidic carbohydrates expressed by L1, but not by 
NCAM, as shown in several experiments:  (a) complex 
formation between L1 and NCAM is inhibited by a 
mAb to oligomannosidic carbohydrates and by the 
oligosaccharides themselves;  (b) NCAM binds to 
oligomannosidic carbohydrates; (c) within the L1/ 
NCAM complex, the oligomannosidic carbohydrates 
are hidden from accessibility to a mAb against oligo- 
mannosidic carbohydrates;  (d) the recombinant protein 
fragment of NCAM containing  the immunoglobulin- 
like domains and not the fragment containing the fibro- 
nectin type III homologous repeats binds to oligoman- 
nosidic glycans. Furthermore,  the fourth immunoglob- 
ulin-like domain of NCAM shows sequence homology 
with carbohydrate recognition domains of animal C-type 
lectins and,  surprisingly,  also with plant lectins.  A 
peptide comprising part of the C-type lectin consensus 
sequence in the fourth immunoglobulin-like domain of 
NCAM interferes with the association between L1 and 
NCAM. 
The functional importance of oligomannosidic gly- 
cans at the cell surface was shown for neurite out- 
growth in vitro. When neurons from early postnatal 
mouse cerebellum were maintained  on laminin  or 
poly-L-lysine, neurite outgrowth was inhibited by oligo- 
mannosidic glycans, by glycopeptides, glycoproteins, 
or neoglycolipids containing  oligomannosidic glycans, 
but not by nonrelated oligosaccharides or oligosaccha- 
ride derivates.  Neurite outgrowth was also inhibited by 
the peptide comprising part of the C-type lectin con- 
sensus sequence in the fourth immunoglobulin-like do- 
main of NCAM.  The combined results suggest that 
carbohydrate-mediated cis-associations between adhe- 
sion molecules at the cell surface modulate their func- 
tional properties. 
T 
HE  specificity  and  efficacy of interactions  between 
cells depend on the cooperativity between molecules 
at the cell surface. In the nervous system, several cell 
surface molecules have been found to be expressed by dis- 
tinct cell types, with one cell capable of expressing  more 
than one molecule that participate  in recognition  and adhe- 
sion at a particular developmental  stage and at a particular 
topographic localization (Edelman and Crossin, 1991; Schach- 
ner,  1991). The implication  is that the developmentally  and 
topographically changing associations of cell surface mole- 
cules are important for the regulation of cell behavior by trig- 
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gering intracellular  signals depending  on the partner mole- 
cules with which they are associated. 
Although  the mechanisms  of such  interactions  have re- 
mained  largely  unknown,  one  pair capable of forming  a 
functional  complex through  cis-interaction  within  the sur- 
face membrane of one cell has recently been recognized:  the 
neural adhesion molecules L1 and neural cell adhesion mole- 
cule (NCAM) ~ can associate with each other thus  leading 
1. Abbreviations  used in this paper:  AMOG,  adhesion molecule on glia; 
GIcNAc,  N-acetylglucosamine;  MAG,  myelin-associated  glycoprotein; 
Man, mannose; NCAM, neural cell adhesion molecule; NCAM-Ig, NCAM 
fragment  containing  the five immunoglobulin-like  domains;  NCAM-FN, 
NCAM fragment containing  the two fibronectin-type Ill homologous re- 
peats; TS101, trisaccharide containing galactose-/31-4-N-acetyl-glucosamine- 
~31-2-mannose. 
© The Rockefeller University Press, 0021-9525/93/06/1409113  $2.00 
The Journal of Cell Biology, Volume 121, Number 6, June 1993 1409-1421  1409 to a  strengthened adhesion to L1  on another cell.  In this 
adhesion mechanism, termed "assisted homophilic binding" 
(Kadmon et al., 1990a), the cis-interaction between L1 and 
NCAM modifies the efficacy of L1 to associate with another 
L1  molecule in a  trans-interaction. The cis-, but not the 
trans-interaction was dependent on the structure of  the oligo- 
saccharides synthesized by the L1  and NCAM expressing 
cells: when the L1 and NCAM dependent aggregation of cul- 
tured neuroblastoma cells was determined after growing the 
cells in the presence of oligosaccharide processing inhibi- 
tors,  a  dependence  on  high  mannose-  or  hybrid-type 
oligosaccharides was observed (Kadmon et al.,  1990b). 
After this lead, we have probed the possibility that oligo- 
mannose-type oligosaccharides recognized  by  the  mono- 
clonal L3 antibody on L1, but not on NCAM  2 (Kficherer et 
al.,  1987)  could be involved in the association of the two 
molecules.  We  report  here  that  the  oligomannose-type 
oligosaccharides carried by L1 mediate the binding of L1 to 
NCAM. Analysis of sequence homologies between NCAM 
and carbohydrate binding molecules revealed motifs charac- 
teristic for the carbohydrate recognition domains of C-type 
lectins and for plant lectins in the fourth immunoglobulin- 
like domain of NCAM.  A peptide comprising part of the 
C-type lectin consensus  sequence in the fourth immuno- 
globulin-like domain not only interfered with the interaction 
between L1 and NCAM, but also inhibited neurite outgrowth. 
Similarly, oligomannosidic glycans and their derivates in- 
hibited neurite outgrowth.  The results implicate carbohy- 
drate-mediated cis-interactions between adhesion molecules 
in important functional roles. 
Materials and Methods 
Glycoproteins 
The neural cell adhesion molecules L1  (Rathjen and Schachner,  1984), 
NCAM (Hoffman et al., 1982), myelin-associated glycoprotein (MAG; Pol- 
torak et al.,  1987), adhesion molecule on glia (AMOG; Antonicek ¢t al., 
1987), and "rest-L2" (L2/HNK-I positive glycoproteins from detergent ex- 
tracts of adult mouse brain after removal of NCAM, L1, and MAG; Kruse 
et al.,  1984) comprising mostly J1-160/180 (Pesheva et al.,  1989) were im- 
munoaffinity purified as described. Proteins were checked for purity by sil- 
ver staining of 8 %  SDS-polyacrylamide  gels according to Merril  et al. 
(1982). No additional bands other than the expected appeared. Ovalbumin 
was  obtained  from  Serva  (Heidelberg,  FRG)  and  ribonuclease  B  and 
asialofetuin from Sigma Chem.  Co.,  St.  Louis, MO. 
Antibodies 
The following antibodies were used: monoclonal LI antibodies 324 (Rath- 
jen and Schachner,  1984) and 555 (Conscience, J.-E, E  Appel, J. Holm, 
E  yon Bohien und Halhach, A.  Faissner, and M.  Schachner, manuscript 
submitted for publication), monoclonal NCAM antibody H28 (Him et al., 
1981), monoclonal L2 antibody 412 (Kruse et al.,  1984), monoclonal L3 
antibody 492 (Kficherer et al.,  1987), monoclonal L5 antibody 487 (Streit 
et al., 1990), and monoclona1473 antibody (Faissner, 1988. Soc. Neurosci. 
Abstr. 920).  mAbs 324, 412,  555, and H28 are of the IgG subclass and 
mAbs 473, 492, and 487 of the IgM subclass. The monoclonal L1, L2, and 
NCAM antibodies were used as protein G (Pharmacia LKB Biotechnology 
Inc., Piscataway, NJ) purified fractions. The mouoclonal L3 antibody was 
used  as  ascites or as  immunopurified IgM  using a  monoclonal  Mark-I 
antibody colunm reacting with rat Ig-kappa chain (Bazin, 1982). Immuno- 
purified preparations were also partially digested with trypsin to obtain 
2. Schmitz, B., J. Peter-Katalinic, H. Egge, and M. Schachner, manuscript 
submitted for publication. 
monovalent fragments of IgM antibody according to Matthew and Reichardt 
(1982). Monoclona1473 and monocional L5 antibodies were used as ammo- 
nium sulfate precipitated preparation of hybridoma supernatant. Polycional 
antibodies were  prepared  in rabbits against  immunoaflinity purified  L1 
(Rathjen and Schachner, 1984), MAG (Poltorak et al., 1987), AMOG (An- 
tonicek et al.,  1987), and NCAM (Faissner et al.,  1984) from adult mouse 
brain. Polyclonal LI and NCAM antibodies were immunoallinity purified 
on L1 and NCAM coupled to Sepharose 4B (Martini and Schachner, 1986) 
and reacted  exclusively  with their respective antigens as  determined by 
ELISA (not shown). Polyclonal AM(g3 and MAG antibodies were used as 
ammonium sulfate precipitated preparations of antisera. Secondary HRP- 
and alkaline phosphatase-conjugated antibodies were obtained from Di- 
anova (Hamburg, FRG). 
Fragments of NCAM 
Protein fragments of NCAM were produced in bacteria in the pET expres- 
sion system (Frei et al.,  1992). One fragment contained the five immuno- 
globulin-like domains from amino acid number 18 to 492 (NCAM-Ig) and 
the other one the two fibronectin type III homologous repeats from amino 
acid number 492 to 692 (NCAM-FN). 
Glycopeptides 
Glycopeptides were prepared from ribonuclease B, ovalbumin, asiolofetuin 
(all from Sigma Chem. Co.), and AMOG by digestion of the glycoproteins 
with pronase (Sigma Chem. Co., catalog no. P-5147; Tai et al.,  1977). En- 
zyme, salts, and digested peptides were removed from glycopeptides by a 
P2 gel filtration column (Biorad Labs.,  Hercules, CA), using 0.1%  acetic 
acid in water as elution solvent. Orcinol positive fractions were collected. 
Neoglycolipids 
Neoglycolipids were synthesized from oligosaccharides released by treat- 
ment with endoglycosidase H  (Boehringer Mannheim Corp.,  Mannheim, 
Germany) of AMOG and ribonuclease B, which expresses only oligoman- 
nosidic glycans (Liang et al., 1980). Neoglycolipids were also derived from 
the oligosaccharide Man5GIcNAc2, the trisaccharide containing galactose- 
/~l-4-N-acetylglucosamine-/31-2-mannose (TSI01), and from lactose (Sigma 
Chem. Co.). The method used and the purification of neoglycolipids is de- 
scribed by Stoll et al. (1988)  2. All neoglycolipids were checked by TLC for 
purity using chloroform/methanol/water (105/100/28,  vol/vol) as  solvent 
and found to contain no starting material of the synthetic reaction. 
Peptide Synthesis 
The following acetylated peptide carboxamides have been synthesized: pep- 
tide MS1 (Ac-Q-V-A-G-D-A-K-D-K-D-I-S-W-F-S-P-N-G-E-NH2) and pep- 
tide MS2 (Ac-E-A-S-G-D-P-I-P-S-I-T-W-R-T-S-T-R-N-I-NH2).  Peptide syn- 
thesis was performed on a Milligen-9050 continuous-flow synthesizer using 
an adapted software package. The Fmoc group was used for N-alpha protec- 
tion throughout, the side-chain protection was the following: N'~-(2,2,5,7,8 - 
pentamethylchroman-6-sulfonyl) for arginine, trityl for cysteine, glutamine 
and asparagine,  (tert-butoxy)carbonyl for lysine, and terthutyl for serine, 
threonine, glutamic acid, and aspartic acid. Synthesis started on the 4-(2',4'- 
dimethoxyphenyl- Fmoc- aminomethyl)- phenoxy  polydimethylacrylamide 
resin and activation was performed by 1,1,3,3-tetramethyl-2-(2-oxo-l(2H)- 
pyridyl)-uronium  tetrafluoro-borate:diisopropylethyl-amine  (1:2,  vol/vol) 
using a fivefold excess of amino acid derivate. Final acetylation was carried 
out manually using acetanhydride in N,N-dimethylformamide in the pres- 
ence of pyridine. The cleavage reaction was performed for 1 h 45 rain in 
a mixture of 1.6 ml H20,  1.6 ml thioanisole, 0.8 ml ethanedithiol, 2 g phe- 
nol, and 32 ml TFA at room temperature. Peptides were purified by Delta- 
Prep-3000 HPLC (Waters Chromatography Division, Milford, MA). From 
64 mg of the crude peptide MS1,  10 nag of purified peptide were obtained 
after preparative HPLC.  14.9 mg of purified peptide MS2 were obtained 
from 75 mg crude material. Ion spray MS on an API III (Sciex, Thornhill, 
Ontario,  Canada) showed the expected ion series. 
Enzyme-linked lmmunosorbent Assays 
Binding  of LI  to  NCAM,  the  NCAM fragment  containing all five 
immunoglobulin-like domains (NCAM-Ig), MAG, or AMOG. Ninety-six- 
well microtiter plates (Falcon 3912) were incubated overnight at 4°C with 
5 #g/ml monoclonal L1 antibody 324 or 555 in PBS (pH 7.4) for substrate- 
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ture with 1% fatty acid-free BSA (Sigma Chem. Co., catalog no. A-7030) 
in PBS. This and all following incubation steps were carried out at room 
temperature. L1 (5/~g/ml) was preincubated with NCAM, MAG, or AMOG 
in PBS containing 0.1% BSA and 0.025%  deoxycholate at a concentration 
of 5/~g/mi and with NCAM-Ig at a concentration of 3/~g/ml. The mixtures 
of molecules were allowed to react with each other for 2 h, and then in- 
cubated with substrate-coated monoclonal LI  antibody 324  or 555  for 
1.5 h. After washing the plates three times with PBS, wells were incubated 
for 1.5 h with polyclonal antibodies to L1, NCAM, MAG, or AMOG in PBS 
containing 1% BSA. Plates were again washed three times with PBS and 
incubated for 1 h with HRP-conjngated anti-rabbit antibodies in PBS con- 
taining 1% BSA. Bound secondary antibodies were visualized by incubation 
with  H202  and  ABTS  (2,2  azino-di-3-ethylbenzthiazoline sulfonate  6; 
Boehringer Mannheim Corp.) as HRP-substrates. The color reaction was 
terminated by addition of 0.6%  aqueous SDS and the OD of the reaction 
product was determined at 405  nm in a  Microtec ELISA reader (Flow 
Labs., Inc., McLean, VA). 
Determination  of the binding of L1 to NCAM in the presence of addi- 
tives. L1 was preincubated with mAbs against carbohydrate epitopes (L2, 
L3, or LS), monovalent fragments of the monoclonal L3 antibody or syn- 
thetic peptides (MSI or MS2) before the incubation with NCAM. Since both 
L1 and NCAM express the 1,2 carbohydrate epitope, not only L1, but also 
NCAM was preincubated with this antibody before allowing them to react 
with each other. NCAM and NCAM-Ig were also preincubated with carbo- 
hydrate  carrying  molecules  (AMOG,  "rest-L2;  glycopeptides prepared 
from AMOG or asialofetuin, and neoglycolipids prepared from oligoman- 
nosidic carbohydrates of ribonuclease B or TS101) before the addition to L1. 
These incubation steps were carried out for 1 h at room temperature in PBS 
at concentrations indicated in the figure legends, before the mixtures of mol- 
ecules were added to substrate-coated monoclonal L1 antibody. The binding 
of L1 and NCAM in the presence of the additives to substrate-coated mono- 
clonal LI antibody was determined as described in the previous paragraph. 
Determination  of the accessibility  of the oligomannosidic  carbohy- 
drate epitope expressed by L1 in the LUNCAM complex.  To determine the 
binding of the monoclonal L3 antibody to L1 after complex formation be- 
tween L1 and NCAM, L1 and NCAM were coated overnight at 4°C in wells 
of microtiter plates either individually or together after a  preincubation 
period of I h at room temperature at a concentration of  2 t~g/mi in PBS each. 
In some experiments, NCAM was preincubated for I h at room temperature 
with a glycopeptide  fraction from ovalbumin (500 t~g/mi), which is enriched 
in oligomannosidic glycans (Tai et al., 1977) before the addition of L1 and 
substrate-coating of the mixture onto microtiter plates. After washing and 
blocking as described above, monoclonal L1, L3, and NCAM antibodies in 
PBS containing 1% BSA were incubated for 2 h at room temperature to 
probe for the accessibility of their respective epitopes. After washing with 
PBS, bound mAbs were detected with HRP-conjugated anti-rat antibodies 
as described above. 
The accessibility of the oligomannosidic carbohydrate epitope in the 
L1/NCAM complex was also determined in another experimental approach. 
Monoclonal L3 antibody was adsorbed overnight at 4"C at 5 #g/ml in PBS 
to micretiter plates and after washing and blocking as above, the mixture 
of preincubated L1 and NCAM was added to the substrate-coated monoclo- 
nal L3 antibody. Binding of L1 and NCAM to monoclonal L3 antibody was 
determined as described above. 
Binding of 1.2, NCAM, or NCAM  fragments to glycolipids. Glycolipids 
dissolved in ethanol (4 ttg/mi) were added to the wells of microtiter plates 
and adsorbed to the plastic by evaporating the ethanol at room temperature. 
Plates were blocked with PBS containing 1%  fatty-acid free BSA for 1 h 
at room temperature. L1, NCAM, or NCAM fragments were added to the 
wells at concentrations of 3 t~g/mi (NCAM fragments) or 5/.tg/ml (L1 and 
NCAM) in PBS containing 0.1% BSA and 0.025% deoxycholate, and in- 
cubated for 2 h at room temperature. In some experiments, substrate-coated 
glycolipids were preincubated with monoclonal L3 antibody for 1 h at room 
temperature before the addition of NCAM. Bound antigens were detected 
with their respective polyclonal antibodies and HRP-eoupled secondary an- 
tibodies as described above. 
Binding  of polyclonal  L1 and NCAM antibodies  to covalently  linked 
antigens.  L1 and NCAM (0.5  #g/rnl) were covalently linked to eovaLink 
microtiter plates (Nunc,  Roskilde, Denmark) according to the manufac- 
turers' instructions. After washing and blocking the plates with PBS con- 
taining 1% BSA for I h at room temperature, polyclonal L1 and NCAM anti- 
bodies were incubated in a  1:2 dilution series on their respective antigens 
for 2 h at room temperature. Bound polyclonal antibodies were detected 
using HRP-coupled secondary antibodies as described above. The coating 
efliciencies  were over 90 % as determined by re,  coating the nonbound L1 and 
NCAM again to covaLink microtiter plates and repeating the ELISA. After 
the second coating, OD values were 10 times lower than after the first coat- 
ing indicating that most of  the molecules were linked to the covaLink micro- 
titer plates after the first coating. 
Determination of the Percentage of  L1 
Molecules Containing the L3 Epitope by 
Sequential Immunoprecipitation 
Immunoaliinity purified L1 antigen (1 ~g/ml) in a final volume of 500 ttl 
PBS was incubated overnight at 4°C with monoclonal L3  antibody (20 
ttg/ml) and,  for control, with monoclonal 473  antibody which does not 
recognize LI. The mixtures were then incubated with polyclonal anti-rat 
IgM antibodies conjugated with biotin (30  /tg/ml) for 2  h  at 4°C.  For 
precipitation, 50/~l streptavidin-agarose beads (Sigma Chem. Co., catalog 
no. S-1638) were added and after another hour of incubation at 4°C, samples 
were centrifuged for 1 rain at 13,000 rpm. Superuatants were removed, in- 
cubated with 50 ttl streptavidin-agarose, and after another hour of incuba- 
tion again pelleted by centrifugation. This procedure was repeated six times, 
and after every centrifugation step an aliquot of the supernatant was re- 
moved  for  SDS-PAGE  (8%  slab  gels)  and  immunoblotting using  im- 
munoaflinity purified polyclonal L1 antibodies and alkaline phosphatase- 
conjugated anti-rabbit antibodies according to Faissner et al. (1985).  The 
de~ction limit for LI was at least 20 ng as determined by parallel assess- 
ment of defined amounts of L1 in a standard curve. After the sixth round 
of clearance with streptavidin-agarose beads, very low amounts of L1 were 
detected by immunoblotting in the supernatants of solutions of L1 treated 
with monoclonal L3 antibody, whereas the full immunoreactivity was de- 
tected in the solutions of L1 treated with monoclonal 473 antibody. 
Determination of  Sequence Homologies 
The Swissprot data base (release 21.0, 3/92)  was used for the search of se- 
quence homologies with the sequence Cxxxxxx(V,I,L)x(S,T)(V,1)xxxx(E,S), 
which is present in all eight carbohydrate recognition domains of  the human 
mannose receptor (Taylor et al., 1990) using the PILEUP program (GCG; 
Devereux et al., 1984).  Alignment of plant lectins, animal C-type lectins, 
and NCAM as well as determination of sequence homologies were also per- 
formed using this program. Alignment parameters are indicated in the leg- 
end to Fig. 7. 
Cell Culture 
Freshly dissociated cell populations enriched in small cerebellar neurons 
(~99% pure) were prepared from 5- to 7-day-old ICR mice (Schnitzer and 
Schachner, 1981; Keilhauer et al., 1985).  Cells were plated at a concentra- 
tion of 2  x  106 cells/ml onto glass coverslips in serum-free, hormone- 
supplemented medium (Fischer et al., 1986) containing 25 mM Hepes (50 
/zl per 16-mm diameter coverslip). Coverslips were coated either with poly- 
L-lysine (10 ttg/ml H20)  or laminin from Engelbreth-Holm-Swarm sar- 
coma (Boehringer Mannheim Corp.; 20/tg/ml in basal medium Eagle's). 
Three coverslips were then placed in 35-mm diameter tissue culture plastic 
petri dishes (Nunc). The medium was removed by gentle suction 3-4 h after 
plating of cells on laminin or 20 h after plating of cells on poly-L-lysine. 
Neoglycolipids, glycopeptides,  oligosaccharides,  glycoproteins, or  syn- 
thetic peptides were then added in 50 #1 medium per coverslip. Cultures 
were examined 24 and 48 h later by phase contrast microscopy. 
Statistical  Analysis 
Statistical  analysis was  performed on nonnormalized data by  one  way 
ANOVA and Scheff6 comparison among means. Differences between values 
were reported as significant (*) when p  was at least <0.05. 
Results 
Determination of the Complex Formation between L1 
and NCAM 
To analyze the interaction between L1 and NCAM,  a solid 
phase assay was developed on the basis of the ELISA.  Im- 
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were allowed to react with each other in Ca++-free  solution 
for 2 h at room temperature. The mixture was then added to 
the monoclonal L1 antibody, which had been preadsorbed to 
plastic  microtiter plates.  As  solely  L1  could  bind  to  the 
substrate-coated mAb,  detection  of NCAM  with its poly- 
clonal  antibodies  was  only  possible  when  NCAM  had 
formed a stable molecular complex with L1 (Fig.  1).  Com- 
plex  formation  between  L1  and  NCAM  (i.e.,  binding  of 
NCAM to L1) was concentration-dependent and in saturation 
when the molecules were incubated at a concentration of 5 
/~g/ml  each  (not  shown).  Incubation of L1  with  MAG or 
AMOG did not result in complex formation between L1 and 
MAG, or AMOG as determined by ELISA with polyclonal 
antibodies to MAG or AMOG, since these antibodies did not 
detect their antigens on substrate-coated monoclonal L1 anti- 
body after preincubation with L1 (Fig. 1). The amount of L1 
bound to the substrate-coated monoclonal L1 antibody was 
controlled using polyclonal L1  antibodies and found to be 
similar in all experiments (Fig. 1). To estimate the quantities 
of L1 and NCAM bound in the complexes, OD values mea- 
sured by ELISA were calibrated for each antigen/antibody 
pair (see Materials and Methods). It was found that approxi- 
mately the same OD values corresponded to the same quanti- 
fies of bound protein for both antibodies. The molar ratio of 
LI:NCAM in the measured complexes was therefore ,,o1:1. 
However, more precise estimates regarding the stoichiome- 
try of this complex cannot be made, since the contribution 
of L1-L1  and NCAM-NCAM interactions are unknown. 
Oligomannosidic Carbohydrates Mediate Binding 
between L1 and NCAM 
To  investigate  whether  the  interaction  between  L1  and 
NCAM depends on oligomannosidic glycans, L1 was prein- 
cubated with the oligomannosidic glycan-specific monoclo- 
nal L3 antibody and with monovalent fragments of this anti- 
body before allowing complex formation with NCAM (Fig. 
2).  As  shown  by  sequential  immunoprecipitation  (see 
Materials and Methods) most if not all L1 molecules carry 
oligomannosidic glycans. A strong inhibition (~ 80 %) of the 
Figure L  Determination  of the  binding  of NCAM,  MAG, and 
AMOG to L1. L1 was preincubated with NCAM, MAG, or AMOG 
before the addition of the mixtures to substrate-coated monoclonal 
L1 antibody. Bound antigens were detected by ELISA using poly- 
clonal antibodies to L1, NCAM, MAG, or AMOG. The OD of the 
reaction product was measured at 405 nm (OD 405). Mean values 
:1: SDs from one representative experiment out of three indepen- 
dent experiments carded in triplicates  are shown. 
Figure 2. Determination of the association between L1 and NCAM 
in the absence or presence of different antibodies or antibody frag- 
ments.  L1  was  preincubated  at  saturating  concentrations  with 
rnonoclonal L1 (555) (L/mab, 50 #g/ml),  L2 (L2 mab, 50 #g/ml), 
L3 (L3 mab, 50/zg/ml), L5 (/_,5 mab, 40 #g/ml) antibodies or mono- 
clonal L3 antibody fragments (L3 mabfrag., 50 #g/ml), before ad- 
dition of NCAM. Also, NCAM was preincubated at saturating con- 
centration  with  monoclonal  L2 antibody  before  addition  to L1. 
After further incubation, the mixtures of molecules were added to 
substrate-coated  monoclonal  L1  antibody  (324).  Bound antigens 
were  detected  by ELISA using  their  respective  polyclonal  anti- 
bodies. Binding of L1 or NCAM to monoclonal L1 antibody in the 
absence of additives was set to 100% (control) and binding of LI 
and NCAM in the presence of additives was expressed in % of the 
control. Mean values +  SDs from at least five independent experi- 
ments carded out in duplicates are shown. 
interaction of L1  with NCAM was observed in the case of 
the monoclonal L3 antibody and a slightly lower inhibition 
(•50%)  in the case of the monovalent antibody fragments, 
as indicated by the reduced binding ofpolyclonal NCAM an- 
tibodies. This reduction was not due to a diminished binding 
of L1 to substrate-coated monoclonal L1 antibody, since L1 
was bound in similar amounts in the absence or presence of 
the  IgM  antibody  or  monovalent fragments.  As  controls, 
monoclonal L1 antibody (555; recognizing the protein back- 
bone),  monoclonal L5  antibody (reacting with a  carbohy- 
drate epitope on L1, but not on NCAM), and monoclonal L2 
antibody (reacting with the L2/HNK-1 carbohydrate on L1 
and NCAM) were used. To prevent cross-linking between L1 
and NCAM in the presence of the monoclonal L2 antibody, 
both molecules were incubated separately with the antibody 
at saturating concentrations before the mixtures of molecules 
were allowed to interact with each other. None of the control 
antibodies significantly inhibited the association of L1 with 
NCAM (Fig.  2). 
The interaction between L1 and NCAM could also be in- 
hibited by the oligomannosidic carbohydrate itself as shown 
by preincubation of NCAM with either neoglycolipids pre- 
pared from ribonuclease B, which carries only oligomanno- 
sidic glycans (Liang et al.,  1980).  Furthermore,  inhibition 
was also observed in the presence of glycopeptides prepared 
from AMOG of adult mouse brain, which carries ,x,30%  of 
its molecular weight in form of N-linked oligosaccharides, 
of  which  75-80%  are  of  the  oligomannosidic  type  2  or 
AMOG (Fig. 3). At 2 #g/ml, AMOG hardy interfered with 
the interaction between L1 and NCAM whereas at 4  #g/ml 
an inhibition  of ~50%  was observed (not  shown).  At 20 
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in the absence or presence of neoglycolipids, glycopeptides, or gly- 
coproteins.  NCAM was preincubated  with oligomannosidic  neo- 
glycolipids prepared from ribonuclease B (Man-nGl); 20/zg/ml), 
oligomannose  containing  glycopeptides  prepared  from  AMOG 
(AMOG-Gp; 500 #g/ml)  and AMOG (AMOG) 20/zg/ml) or, for 
control,  with lactosylneoglycolipid (Lacto-nGl; 20/zg/ml), TSI01- 
neoglycolipid  (TSIOI-nGI; 200  /zg/ml),  a  glycopeptide  prepared 
from asialofetuin (af-Gp; 500/~g/mi),  and with "rest L2; the L2/ 
HNK-I carbohydrate  containing  glycoprotein fraction  from adult 
mouse brain (~rest  L2; 20/~g/ml) before the addition of L1. After 
further incubation,  the mixtures of molecules were added to sub- 
strate-coated  monoclonal  LI antibody.  Bound antigens were de- 
tected by ELISA using their respective polyclonal antibodies. Bind- 
ing of LI and NCAM to monoclonal L1 antibody in the absence of 
additives was set to 100% (control) and binding of L1 and NCAM 
in the presence of additives was expressed in % of control.  Mean 
values  +  SDs from at least two independent experiments carried 
out in duplicates are shown. 
/~g/ml  a  complete inhibition of the association between L1 
and NCAM was observed (Fig. 3). No significant inhibition 
of the L1/NCAM association was observed in the presence 
of neoglycolipids derived from the neutral disaccharide lac- 
tose and the trisaccharide TS101, which are not recognized 
by the monoclonal L3 antibody, neutral glycopeptides pre- 
pared  from  asialofetuin  (Hatton  et  al.,  1979)  and  the 
L2/HNK-1  carbohydrate  containing  glycoprotein  fraction 
from adult mouse brain, which is also not recognized by the 
monoclonal L3 antibody (Fig.  3). 
Interaction of  L1 and NCAM Leads to a Reduced 
Accessibility of the Oligomannosidic Carbohydrate 
Epitope to the Monoclonal L3 Antibody 
To investigate the accessibility of the oligomannosidic carbo- 
hydrate in the L1/NCAM complex, the ability of the mono- 
clonal L3 antibody to react with its epitope in the complex 
was determined. Substrate-coated L1 gave a strong reactivity 
with  the  monoclonal  L3  antibody,  which  was  reduced  to 
50%  when  L1  was preincubated with  NCAM before sub- 
strate-coating  the  mixtures  of molecules  onto  microtiter 
plates.  The reduced binding of monoclonal L3 antibody to 
the L1/NCAM complex could be reversed by preincubating 
NCAM  with  glycopeptides  from  ovalbumin,  which  are 
strongly  enriched  in  oligomannosidic  glycans  (Tai  et  al., 
1977),  before complex formation with L1 (Fig. 4).  The ac- 
cessibility of monoclonal L1  or NCAM antibodies to their 
respective antigens was not changed by complex formation 
Figure 4. Determination of the accessibility of the L3 carbohydrate 
epitope in the LI/NCAM complex in absence or presence of oligo- 
mannosidic  glycopeptides  derived  from ovalbumin.  L1  (L/) and 
NCAM (NCAM) were coated as substrates either individually or 
as mixture (LI/NCAM). The mixture of L1 and NCAM was also 
coated after preincubation  of NCAM with glycopeptides of oval- 
bumin (LI/NCAM/Ov-GP). Glycopeptides  of ovalbumin did  not 
bind to the plastic of the microtiter plates (not shown). Binding of 
monoclonal L1 and L3 antibodies to L1 and binding of monoclonal 
NCAM antibody  to NCAM was measured  by ELISA and set to 
100 % for individually coated antigens. Binding of these antibodies 
to the mixtures was expressed in % of mAb binding to the individ- 
ually coated antigens. Mean values +  SDs from three independent 
experiments  carried  out in duplicates are shown. 
(Fig. 4). Further evidence that the oligomannosidic carbohy- 
drate epitope carried by L1 is hidden from accessibility to 
the monoclonal L3 antibody in the L1/NCAM complex came 
from experiments,  in which  monoclonal L3  antibody was 
coated as substrate and the L1/NCAM complex was then al- 
lowed to interact with the antibody. No binding of the com- 
plex could be detected,  whereas in the control experiment 
with substrate-coated monoclonal L1 antibody the L1/NCAM 
complex was readily bound (not shown). 
NCAM Binds to Substrate-bound 
Oligomannosidic Glycans 
As oligomannosidic glycans carried by L1 are required for 
the L1/NCAM complex formation, NCAM must be a recep- 
tor or lectin for these carbohydrates. The ability of NCAM 
to  serve  as  lectin  for  oligomannosidic  glycans  could  be 
shown  by  the  binding  of  NCAM  to  substrate-coated 
oligomannosidic glycan containing neoglycolipids (Fig. 5). 
NCAM did not bind to the neoglycolipid containing the neu- 
tral trisaccharide TS101 or to BSA. The binding of NCAM 
to the substrate-coated oligomannosidic neoglycolipids was 
reduced after preincubation of the oligomannosidic neogly- 
colipid substrate with monoclonal L3 antibody (Fig. 5). As 
control,  L1  was shown not to bind to the substrate-coated 
oligomannosidic neoglycolipids (Fig.  5). 
The Immunoglobulin-like Domains and Not the 
Fibronectin 13jpe III Homologous Repeats of  NCAM 
Bind to Oligomannosidic Glycans and Are Involved in 
L1/NCAM Complex Formation 
The bacterially expressed protein fragment of NCAM con- 
taining the five immunoglobulin-like domains also bound to 
substrate-coated oligomannosidic neoglycolipids, but not to 
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ments to oligomannosidic neoglycolipids. NCAM, NCAM frag- 
ments comprising the immunoglobulin-like domains (NCAM-Ig) or 
fibronectin type HI homologous repeats (NCAM-FN) and L1 were 
added to substrate-coated oligomannosidic neoglycolipids  prepared 
from ribonuclease B (Man-nGl substrate), to TS101-neoglycolipid 
(TSIOI-nGI substrate), or to BSA (BSA substrate). All three sub- 
strates were also preincubated with monoclonal L3 antibody before 
addition of NCAM (NCAM+L3 mab). Bound antigens were de- 
tected by ELISA using their respective polyclonal antibodies. Bind- 
ing of NCAM to substrate-coated Man-riG1 was set to 100% and 
binding of NCAM to TS101-nG1  and BSA or of L1 to all substrates 
was expressed in % of binding of NCAM to Man-nGl. Binding of 
NCAM-Ig to substrate-coated Man-nGl was also set to 100%, and 
binding of NCAM-Ig to TS101-nG1  or BSA and binding of NCAM- 
FN to substrate-coated Man-nG1 or BSA was expressed in  % of 
binding of NCAM-Ig to Man-nGl. Mean values +  SDs from three 
different experiments carried out in duplicates are shown. 
the control neoglycolipid or to BSA (Fig. 5). The bacterially 
expressed protein fragment of NCAM  containing the two 
fibronectin type III repeats hardly bound to the oligomanno- 
sidic neoglycolipid substrate (Fig. 5). 
The five immunoglobulin-like domains of NCAM also in- 
teracted with L1 (Fig. 6). Preincubation of L1 with monoclo- 
nal  L3 antibody reduced the binding of L1  to the protein 
fragment containing the  immunoglobulin-like domains  of 
NCAM (Fig. 6). Furthermore, preincubation of this NCAM 
fragment with oligomannosidic neoglycolipids also prevented 
the binding of the NCAM fragment to L1. The control neo- 
glycolipid TS101 was ineffective in preventing the binding of 
the NCAM fragment to L1 (Fig. 6). 
The Fourth Immunoglobulin-like Domain of 
NCAM Shows Sequence Similarity to Carbohydrate 
Recognition Domains 
Since the carbohydrate recognition domains of several types 
of  mannose-specific  carbohydrate  binding  proteins  have 
been determined in 'their primary structure, it seemed worth- 
while to determine whether NCAM shows sequence homol- 
ogies with any of these domains. The primary sequences of 
all  eight carbohydrate recognition domains  of the human 
mannose receptor (Taylor et al., 1990) could be aligned with 
the  amino  acid  sequence  Cxxxxxx(V,I,L)x(S,T)(VI)xxxx 
(E,S).  This  sequence  was  identified  within  the  fourth 
immunoglobulin-like domain of mouse NCAM  starting at 
amino  acid  number  330  and  also  in  37  other  proteins. 
Figure 6. Determination of the binding of L1 to the bacterially ex- 
pressed NCAM fragment containing the immunoglobulin-like do- 
mains (NCAM-Ig) in the absence or presence of monoclonal L3 an- 
tibody or oligomannosidic neoglycolipids. L1  was preincubated 
with monoelonal L3 antibody (L3 mab) and NCAM-Ig was pre- 
incubated with an oligomannosidic neoglycolipid prepared from ri- 
bonuclease B (Man-nGl, 20 #g/ml) or, for control,  with TS101- 
neoglycolipid (TS101-nGI,  200 #g/ml) before addition of NCAM-Ig 
or L1, respectively. After further incubation, the mixtures were 
added to substrate-coated monoclonal L1 antibody. Bound antigens 
were detected by ELISA using their respective polyclonal anti- 
bodies. Binding of L1 and NCAM-Ig in the absence of additives 
were set to 100% (control) and binding of L1 and NCAM-Ig in the 
presence of additives expressed in % of the control. Mean values 
+  SDs from one representative out of three independent experi- 
ments carried out in triplicates are shown. 
Among the other proteins expressing this sequence, several 
are  known to be lectins,  as  for example the Kupffer cell 
receptor (Hoyle and Hill, 1991), the low affinity Fc receptor 
of IgE (Bettler et al., 1989), the cartilage-specific proteogly- 
can core protein  (Doege et al.,  1987),  the hepatic  lectin 
homolog (Tomley et al.,  1988), or versican (Krusius et al., 
1987). 
We  further compared  the  amino  acid  sequence  of the 
fourth immunoglobulin-like domain of NCAM without the al- 
ternatively spliced 7r exon (Santoni et al,, 1989) with the se- 
quence of the carbohydrate recognition domain four of the 
human mannose receptor, shown to be functionally most ac- 
tive in carbohydrate binding (Taylor et al.,  1992), with the 
consensus sequence for C-type lectins according to Weis et 
al.  (1991),  and to the alpha chain of the mannose/glucose 
specific  lectin  from Lathyrus  ochrus  (Richardson  et  al., 
1984). We found a similarity of 37% at the protein level be- 
tween the fourth and the beginning of  the fifth immunoglobu- 
lin-like domain of mouse NCAM (from amino acid 323 to 
439) and the carbohydrate recognition domain four of  the hu- 
man mannose receptor (from amino acid 673 to 781). In the 
amino-terminal half of the fourth immunoglobulin-like do- 
main of NCAM we could align 6 out of 10 amino acids of 
the consensus sequence of C-type lectins according to Weis 
et al. (1991) (Fig. 7). Surprisingly, the carboxy-terminal half 
of the fourth and the beginning of the fifth immunoglobulin- 
like domains (from amino acid 368 to 421 of mouse NCAM) 
showed sequence homology to plant lectins from legumin- 
oses. The amino acid sequence of the alpha chain of man- 
nose/glucose specific lectin from Lathyrus ochrus, which is 
nearly identical with Lathyrus sativus (Sletten et al.,  1983) 
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MR4  human  673  WFESRDFCRA  LGGDLASINN  KEEQQTIWRL  ITASGSYHKL  FWLGLTYGSP  S-EG-FTWSD  -GSP-VSYE-  NWAYGEPNN-  -yQNVEYCGE  LKGDPTM-SW  N  ....  DINCE  HLNNWICQIQ 
:  I  I  ]:.:;[I.  :  ....  I  ....  ::  :  :  ,.  :.  •  -;  ;  :.L  ''  •  •  :.~...  i  :t:l...  ;.I...:  .I  :  :i. IL  -  ' 
Ncam  human  322  EEQVTLTCEA  SGDPIPSITW  RTSTRNISSE  EKTLDG-HMV  VRSHARVSSL  TLKS-IQYTD  -AGEYICTA-  SNTIGQDSQS  MYLEVQYAPK  LQGPVAVYTW  EGNQVNITCE  VFAYPSATiS 
Ncam  rat  323  EEQVTLTCEA  SGDPIPSITW  RTSTRNISSE  EKTLDG-HMV  VRSHARVSSL  TLKS-IQYTD  -AGEYICTA-  SNTIGQDSQS  MYLEVQYAPK  LQGPVAVYTW  EGNQVNITCE  VFAYPSATIS 
Ncam  bovine  321  EEQVTLTCEA  SGDPIPSITW  RTSTRNISSE  EKTLDG-H~4V  VRSHARVSSL  TLKS-IQYTD  -AGEYVCTA-  SNTIGQDSQS  MYLEVQYAPK  LQGPVAVYTW  EGNQVNITCE  VFAYPSATIS 
Ncam  mouse  323  EEQVTLT~SSE  EkDLDG-}~4V  VRSHARVSSL  TLKS-IQYtD  -AGEYiCTA-  SNTIGQDSQS  myLEvQYAPK  LQGPVAVYTW  EGNQVNITCE  VFAYPSATIS 
Ncam  chick  310  EDQITLTCEA  SGDPIPSITW  KTSTRNISNE  EKTLDG-RIV  VRSHARVSSL  TLKE-IQYTD  -AGEYVCTA-  SNTIGQDSQA  MYLEVQYAPK  LQGPVAVYTW  EGNQVNITCE  VFAYPSAVIS 
Ncam  Xenop  316  LDEITLTCEA  SGDPIPSITW  RTAVRNISSE  ATTLDG-HIV  VKEHIP/~SAL  TLKD-IQYTD  -AGEYFCIA-  SNPIGVDMQA  MYFEVQYAPK  IRGPVVVYTW  EGNPVNITCE  VFAHPRAAVT 
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Figure 7. Comparison of the amino acid sequence of the fourth immunoglobulin-like  domain of NCAMs from different species with C-type 
and plant lectins.  Alignment of MR4 (carbohydrate recognition domain four of the human mannose receptor; Taylor et al.,  1990) with 
the fourth immunoglobulin-like domain of NCAM from different species  (human NCAM: Barton et al.,  1988; rat NCAM: Small et al., 
1987; bovine NCAM: Lipkin et al.,  1989; mouse NCAM: Barthels  et al.,  1987; Montag, D., and E  Lahrtz, personal communication; 
chicken NCAM: Cunningham et al.,  1987; Xenopus laevis NCAM: Krieg et al.,  1989) was performed using the following parameters: 
gap wt =  2.0, gap length wt =  0.1. Alignment of the entire sequence of Lecal (alpha  1 chain of the mannose/glucose-specific  lectin from 
Lathyrus ochrus; Richardson et al.,  1984) with the fourth immunoglobulin-like  domain of NCAM was performed using the following pa- 
rameters: gap wt =  1.0, gap length wt =  1.0. Vertical bars between the alignments  indicate  identical amino acids in all sequences.  Double 
points indicate  a minimal comparison value of 0.5 and single points  indicate  a minimal comparison value of 0.1, when compared to the 
amino acid with the lowest homology, in the NCAM sequences using the standard Dayhoffs amino acid comparison table. Numbers indicate 
the amino acids at the start sites of the protein segments used for the alignment.  Characters above the alignment  indicate  the relevant sites 
in the mouse NCAM sequence which are specific for C-type lectins (Weis et al.,  1991; C, cysteine,/~,  aliphatic  amino acid). The ~r below 
the alignment indicates  the site where the alternatively  spliced  ~r-exon is located in the NCAM sequence (not included).  The sequence 
of peptide MS2 of mouse NCAM is underlined. 
and  Vicia cracca (Bauman et al.,  1982),  was used for this 
comparison. The fourth immunoglobulin-like domain showed 
a similarity of 43 % at the protein level to the alpha chain of 
Lathyrus ochrus lectin (total length 53 amino acids) (Fig. 7). 
A  Peptide Comprising Part of the C-type 
Lectin Consensus Sequence in the Fourth 
Immunoglobulin-like Domain of NCAM Interferes 
with L1/NCAM Interaction 
As it is possible to prevent the binding of oligosaccharide 
structures  to  their  corresponding  receptors  by using  syn- 
thetic  peptides  containing  the amino acid sequence of the 
receptor domain  (see for example,  Geng et al.,  1991),  we 
used the peptide MS2 representing  19 amino acids starting 
at glutamic acid-331 at the amino-terminal end of the fourth 
immunoglobulin-like domain of mouse NCAM as competi- 
tor  for the  L1/NCAM interaction.  This  peptide  comprises 
part of the C-type lectin consensus sequence. Preincubation 
of L1 with this peptide prevented the association of L1 with 
NCAM in a concentration-dependent manner (Fig.  8).  The 
control peptide MS1 starting at glutamine-42,  which repre- 
sents the first 19 amino-terminal amino acids of the first im- 
munoglobulin-like domain of NCAM did not interfere with 
the interaction between L1  and NCAM (Fig.  8). 
Oligomannosidic Glycans Are Implicated in Neurite 
Outgrowth from Early Postnatal CerebeUar Neurons 
The  oligomannosidic L3  epitope has been detected by in- 
direct immunofluorescence studies at the cell surface of  cere- 
bellar neurons (Kficherer et al.,  1987). To study their func- 
tion  at  the  neuronal  cell  surface,  neurons  from  early 
postnatal mouse cerebellum were maintained on substrates 
of poly-L-lysine or laminin  in the presence  or absence of 
oligomannosidic glycans, neoglycolipids, glycopeptides, or 
glycoproteins.  For  control,  other  neutral  glycans  or 
glycoconjugates were used  (Table I).  Laminin and poly-L- 
lysine do not carry oligomannosidic glycans (not shown). 
Outgrowth of neurites could be observed after ,04 h on poly- 
L-lysine, whereas on laminin neurites were formed already 
shortly after cells had adhered.  The addition of mannosidic 
glycoconjugates after the first neurites had extended resulted 
in a  dramatic  decrease  of neurite  outgrowth on both  sub- 
strates.  One day after addition of glycoconjugates, neurites 
were  shorter  on  laminin  in  the  presence  of  1  and  5  /~M 
oligomannosidic  neoglycolipids  than  in  their  absence, 
Figure 8. Determination of the association between L1 and NCAM 
in the absence or presence of peptides  MS1 and MS2 containing 
the first 19 amino acids of the first and fourth immunoglobulin-like 
domain of NCAM, respectively. L1 was preincubated with increas- 
ing amounts of peptide  MS2 and,  for control, with peptide MS1 
(2 mg/ml) before the addition of NCAM. After further incubation, 
the mixtures were added to substrate-coated  monoclonal L1 anti- 
body. Bound antigens  were detected by ELISA using their respec- 
tive polyclonal antibodies.  Binding of  L1 and NCAM to monoclonal 
LI antibody in the absence of peptide  MS2 was set to 100% (con- 
trol) and binding of L1 and NCAM in the presence of peptide MS2 
expressed  in % of control. In the presence of peptide MS1, binding 
of L1 to substrate-coated  monoclonal L1  antibody was  inhibited 
when added either alone or together with NCAM. Therefore, bind- 
ing of NCAM was expressed  relative  to the binding of L1, which 
was set to 100%.  Mean values  +  SDs from three independent  ex- 
periments carded out in duplicates  are shown. 
Horstkorte et al. NCAM  Is a Lectin  for Oligomannosidic Glycans  1415 Table L List of  Oligosaccharides, Neoglycolipids, and Glycoproteins Used  for the Study of  Inhibition of  Neurite Outgrowth 
from Early Postnatal Cerebellar  Neurons 
Type of oligosaccharide  Type of glycoconjugate  Concentration 
~M) 
Oligomannosidic  Oligosaccharide  50-200 #M* 
(from AMOG, ovalbumin  Neoglycolipid  1-10 t~M* 
or ribonuclease B)  Glycopeptide  50-200 I~M* 
Glycoprotein (not AMOG)  100/~M 
Man~GlcNAc2  Neoglycolipid  10 t~M 
Lactose  Oligosaccharide  200/zM 
Neoglycolipid  10 #M 
GaI-GlcNAc-Man  Oligosaccharide  200/zM 
Neoglycolipid  10 #M 
Laeto-N-tetraose  Oligosaccharide  200 #M 
Non-sialylated complex type  Glycopeptide  200 #M 
(from asialofetuin)  Glycoprotein  100 #M 
* Complete inhibition  was observed at the highest concentration  indicated. 
whereas in the presence of 10 #M oligomannosidic neogly- 
colipids or 200/zM oligomannosidic  glycopeptides, virtually 
no neurites could be seen (Fig. 9, C and D). Neurites which 
had been  formed before the addition of oligomannosidic 
compounds appeared to become degraded. One day after ad- 
dition of 10/,M oligomannosidic neoglycolipids, a reduced 
neurite outgrowth was seen on poly-L-lysine  compared to the 
control  in  the  absence  of added  oligomannosidic  com- 
pounds, with many neurons (~20-30%) not developing any 
neurites. After two days, more than 90 % of all cells were 
devoid of neurites on both substrates (not shown). No sig- 
nificant difference in viability of cells was observed between 
cultures maintained in the presence or absence of additives 
as judged by the exclusion of trypan blue. Removal of the oli- 
gomannosidic compounds by change of the culture medium 
one day after their addition led to a partial regrowth of neu- 
rites from ~30-40% of all neurons (not shown). The inhibi- 
tory effects of oligomannosidic oligosaccharides or glyco- 
peptides were the same as of neoglycolipids, although much 
higher concentrations were necessary (Table I; Fig. 9, C and 
D). There was also no difference to observe whether manno- 
sidic  oligosaccharides,  glycopeptides,  or  neoglycolipids 
were derived from either AMOG, ribonuclease B, or ovalbu- 
min (not shown). Neurite outgrowth was not affected in the 
presence of several other neoglycolipids, oligosaccharides, 
glycopeptides containing neutral oligosaccharides, or in the 
presence of asialofetuin (Table I, Fig. 9 B). No binding of 
oligomannosidic neoglycolipids to laminin or poly-L-lysine 
substrates was detectable by ELISA (not shown). 
Neurite Outgrowth Is Inhibited in the Presence of 
the Synthetic Peptide Comprising Part of the C-type 
Lectin Consensus Sequence in the Fourth 
Immunoglobulin-like Domain of  NCAM 
Since  oligomannosidic  glycans  may  interfere  with  the 
L1/NCAM interaction at the cell surface, the peptide com- 
prising part of the C-type lectin consensus sequence in the 
fourth immunoglobulin-like domain of NCAM should have 
similar effects on neurite outgrowth as the oligomarmosidic 
glycans. When the peptide was added to the culture medium 
of cerebellar neurons,  a  strong inhibition of neurite out- 
growth was observed after 1 d (Fig. 10 C). After 2 d, more 
than 90% of all cells were devoid of neurites (Fig.  10 D). 
When cells were maintained in the presence of the control 
peptide derived from the first immunoglobulin-like domain 
of NCAM,  neurite outgrowth was unaffected (Fig.  10,  A 
and B). 
The combined observations from these cell culture experi- 
ments indicate that an interaction between cell surface ex- 
pressed oligomannosidic glycans with the carbohydrate rec- 
ognition domain of the fourth immunoglobulin-like domain 
of NCAM is implicated in neurite outgrowth. 
Discussion 
In our study we present evidence that the ability of L1 and 
NCAM to interact with each other is based on oligomanno- 
sidic glycans carried by L1, but not by NCAM.  This was 
shown in experiments in which the association between L1 
and NCAM could be inhibited by different glycoconjugates 
carrying oligomannosidic glycans. The same results were 
obtained independent of the source of oligomannosidic gly- 
cans, i.e., whether they were derived from AMOG, ovalbu- 
min,  or ribonuclease B.  The association between L1  and 
NCAM was also strongly inhibited by the oligomannosidic 
glycan recognizing monoclonal L3 antibody. Although this 
antibody is of the IgM subtype, the inhibition observed ap- 
pears to be specific and not due to sterical hindrance for the 
following reasons: First, monovalent fragments of this anti- 
body also gave significant inhibition. Second, the monoclo- 
nal L5 antibody, which is also an IgM and binds to a carbo- 
hydrate epitope on L1 (Streit et al.,  1991) did not interfere 
with the interaction between L1 and NCAM. Third, inhibi- 
tion was not observed in the presence of the mAb recogniz- 
ing the sulfated L2/HNK-1 carbohydrate which is carried by 
L1 and NCAM (Kruse et al., 1984). Fourth, other glycopro- 
teins  expressing  the  L2-HNK-1  epitope,  which has  been 
shown in several studies to be functionally important in cell 
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graphs  of  small  cerebeUar 
neurons  cultured  in  the  ab- 
sence or presence of different 
glycoconjugates. Early post- 
natal small cerebeUar neurons 
were plated on laminin-coated 
glass coverslips. After 3 h, the 
culture medium was ¢x~hanoocd 
with  culture  medium  con- 
talning  no  additives  (A), or 
containing 10 #M lactosyl-neo- 
glycolipid (B), 10 #M oligo- 
mannosidic neoglycolipids  de- 
rived  from  AMOG  (C),  or 
200 #M oligomannosidic gly- 
copeptides derived from ribo- 
nuclease (D).  Phase contrast 
micrographs were taken 24 h 
after the change of  culture me- 
dium. Bar in A represents 20 
#m for A-D. 
adhesion and neurite outgrowth (Bronner-Fraser, 1987; Dow 
et al.,  1988; Kiinemund et al.,  1988; Martini et al.,  1992; 
Hall et al.,  1993),  also did not interfere with L1/NCAM 
complex formation.  Fifth,  a  mAb recognizing the protein 
backbone of L1 did not inhibit the L1/NCAM interaction. 
The direct binding of NCAM to oligomannosidic glycans 
could also be shown to be specific. The combined observa- 
tions support the contention that in the L1/NCAM interac- 
tion, NCAM  functions as a  carbohydrate binding protein. 
Thus NCAM is, in the strict sense of the definition, a lectin 
in that it is a receptor for particular carbohydrates, but not 
for others. 
That NCAM is a receptor for oligomannosidic glycans is 
underscored by the finding that sequences characteristic of 
two different types of lectins can be localized within the 
fourth and the beginning of the fifth immunoglobulin-like 
domain of NCAM.  Comparison with the C-type carbohy- 
drate recognition domain four of the human marmose recep- 
tor (Taylor et al.,  1990) yielded a similarity of 37%, with 
the highest homology being found at the amino-terminal end 
of the fourth immunoglobulin-like domain of NCAM. Inhi- 
bition studies with a synthetic peptide comprising the first 19 
amino  acids  of  the  amino-terminal  end  of  the  domain 
confirmed that this part is functionally active. A few amino 
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crographs of small cerebellar 
neurons cultured  in the absence 
or presence of  NCAM-derived 
peptides. Early postnatal small 
cerebellar neurons were plated 
on poly-L-lysine-coated glass 
coverslips. After 20 h, the cul- 
ture  medium  was  exchanged 
with culture medium contain- 
ing no additives (E and F) or 
containing a peptide (1 raM) 
comprising 19 amino acids of 
the first (.4 and B) or a peptide 
(1 mM) comprising 19 amino 
acids of the  fourth immuno- 
globulin-like  domain  of  NCAM 
(Cand D). Phase contrast mi- 
crographs were taken 24 (A, C, 
and E) or 48 h (B, D, and F) af- 
ter the change of culture me- 
dium. Bar in A represents 10 
#m for A-F. 
acids of the consensus sequence for carbohydrate recogni- 
tion domains of C-type lectins (Weis et al., 1991) could also 
be aligned at corresponding positions within this peptide. 
Most surprisingly,  the carboxy-terminal half of the fourth 
and the beginning of the fifth immunoglobulin-like domains 
of NCAM showed a similarity of 43 % to the alpha chains of 
a  group  of mannose/glucose  specific  plant  lectins  from 
leguminoses  (Richardson  et  al.,  1984).  Thus,  as  to  our 
knowledge, we describe here for the first time a sequence ho- 
mology between animal and plant lectins. A C-type carbohy- 
drate recognition domain has recently been detected in per- 
tussis toxin, a prokaryotic protein (Saukkonen et al., 1992). 
This finding and our observations indicate that the sequence 
for carbohydrate recognition domains  of plants,  bacteria, 
and  animals  are  phylogenetically conserved.  Another in- 
teresting aspect is that within NCAM, structurally different, 
but functionally similar domains from animal and plant lec- 
tins are combined. We do not know whether the presence of 
two different types of lectin-homologous sequences implies 
that there are multiple binding sites for oligomannosidic gly- 
cans.  Nevertheless, at least part of the binding capacity re- 
sides in the amino-terminal half of the fourth immunoglobu- 
lin-like  domain,  as  the  corresponding  synthetic  peptide 
inhibited the association between L1 and NCAM. 
Some characteristic properties of the lectin-like domains 
of NCAM are worth being considered in more detail. C-type 
and  plant  lectins  interact  with  their  ligands  in  a  Ca  ++- 
dependent manner.  However, L1 and NCAM bind to each 
other  in  the  absence  of Ca  ++  .  Interestingly,  amino  acids 
which are thought to be important for Ca÷+-binding  (amino 
acids D, N, E, or Q with side chains carrying carbonyl oxy- 
gen atoms at numbers 161 and 165 of the C-type lectin se- 
quence according to Weis et al.,  1991) are not contained in 
the amino acid sequence of NCAM.  Ca  ++ is believed to be 
important  for providing the  carbohydrate recognition do- 
main with a specific conformation for high affinity binding 
of ligands at physiological pH and for low affinity binding in 
the low pH environment of endosomes (Weis et al.,  1991). 
The absence of the amino acids in the NCAM sequence im- 
portant for Ca  ++ binding suggests that this change in affinity 
might not be relevant for the binding of oligomannosidic 
ligands to NCAM at the cell surface. 
Oligomannosidic glycans are thought to mainly occur in 
the  ER  as  precursors  of  complex-type  oligosaccharides 
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faces as they could be detected with the monoclonal L3 anti- 
body on cell surfaces of neurons, subpopulations of astro- 
cytes, and oligodendrocytes (Kiicherer et al.,  1987; Fahrig 
et al., 1990). These carbohydrates are indeed involved in im- 
portant cellular functions: Neurite outgrowth was strongly 
inhibited when oligomannosidic  glycoconjugates  were added 
as putative competitors of cell-bound glycans to the culture 
medium.  Oligomannosidic  neoglycolipids  derived  from 
oligosaccharides  of  AMOG  or  ribonuclease  B  and  the 
MansGlcNAc2 glycan were most potent in inhibiting neurite 
outgrowth. Inhibition of neurite outgrowth was also seen in 
the  presence  of  free  mannosidic  oligosaccharides  or 
glycopeptides, although they were about 20 times less effec- 
tive on a molar basis than the glycolipids. This difference is 
most likely due to the fact that neoglycolipids exist in aque- 
ous solution as micelles that carry multiple carbohydrate epi- 
topes  in  contrast  to  the  monovalent oligosaccharides  or 
glycopeptides,  which  have  been  shown  to  display  lower 
affinity to their binding sites than multimers (see for exam- 
ple, Kiinemund et al., 1988).  The inhibition of neurite out- 
growth in the presence of the neoglycolipids was probably 
not the result of their incorporation into cell membranes and 
subsequently intracellular compartments, because such an 
uptake is not known to exist for free oligosaccharides or 
glycopeptides, in the presence of which exactly the same 
effects as for glycolipids were observed.  Furthermore, no 
influence on neurite growth could be detected in the presence 
of other neutral neoglycolipids, oligosaccharides, or glyco- 
peptides including those from asialofetuin which were all 
prepared exactly the same way and mostly even in parallel 
so that the possibility can be excluded that the effects ob- 
served were due to any cytotoxic contaminations not detect- 
able  by  either  thin  layer chromatography or  mass  spec- 
trometry  2. 
The effects on neurite growth caused by the oligomanno- 
sidic glycans raised the question as to the molecular mecha- 
nism(s). Since L1 appears to be the only glycoprotein on cer- 
ebellar neurons to carry oligomannosidic glycans (Kiicherer 
et al., 1987) it can be assumed that L1 is the main cell surface 
glycoprotein  which  is  involved  in  the  oligomannosidic 
carbohydrate-dependent  effect  on  neurite  growth.  Also, 
since L1 and NCAM are coexpressed on cerebellar neurons 
and associate with each other within the cell surface as de- 
scribed for neuroblastoma ceils (Kadmon et al.,  1990a,b), 
this cis-interaction  is most likely competitively inhibited in 
the presence of oligomannosidic carbohydrates. Inhibition of 
neurite outgrowth in the presence of a synthetic peptide com- 
prising part of the C-type lectin consensus sequence in the 
fourth immunoglobulin-like domain of NCAM  implicates 
also  NCAM  in  this  interaction.  The  perturbation  of the 
L1/NCAM complex at the cell surface thus may affect intra- 
cellular reactions, which in turn could influence neurite out- 
growth. Since poly-L-lysine and laminin were used as sub- 
strates to assay oligomannosidic glycan inhibitable neurite 
outgrowth, the question remains to be addressed, why a dis- 
turbance of oligomannosidic carbohydrate-receptor interac- 
tion at the cell surface may influence cell-substrate interac- 
tions which are not suspected or known to depend on the 
L1/NCAM complex. While the cell surface receptors medi- 
ating  neurite outgrowth on poly-L-lysine are not known, 
laminin is thought to promote neurite outgrowth via integrin 
cell surface receptors.  Since we could exclude that oligo- 
mannosidic glycans mediate trans-interactions  between cells 
and laminin or poly-L-lysine, and since it is unlikely that 
these cell-substrate interactions are inhibitable by the syn- 
thetic peptide comprising part of the C-type lectin consensus 
sequence  of  the  fourth  immunoglobulin-like  domain  of 
NCAM, the inhibitory effects of these substances can be at- 
tributed to the cis-interaction  between L1 and NCAM. The 
ways by which L1 and NCAM may modulate integrin medi- 
ated neurite outgrowth are presently not known. It is con- 
ceivable that the signal transduction mechanisms involved in 
neurite outgrowth (Bixby,  1989; Bixby and Jhabvala, 1990; 
Doherty et al.,  1991, 1992)  are interconnected, such that 
perturbance of one may influence another signaling cascade. 
Preliminary evidence suggests that signal transduction is in- 
deed involved in L1/NCAM interaction, as oligomannosidic 
neoglycolipids increased intracellular levels of inositol phos- 
phates (von Bohlen und Halbach and Schmitz, unpublished 
results), It remains to be seen by which intracellular mecha- 
nisms the oligomannosidic oligosaccharides or the synthetic 
peptide evoke changes in neurite outgrowth. The immuno- 
globulin-like domain four contains a variable alternatively 
spliced exon (~r- or VASE-exon) consisting of 10 amino acids 
(Santonl et al., 1989;  Small et al.,  1990).  The presence of 
this exon may lead to an altered three-dimensional structure 
of the immunoglobulin-like domain and thus to a change in 
the binding of oligomannosidic glycans. This is of interest 
in view of the observation that cerebellar and hippocampal 
cells downregulate their neurite outgrowth at developmental 
stages where the expression of the ~r-exon is enhanced and, 
vice versa, neurite outgrowth is increased when the lr-exon 
is expressed at low levels (Walsh et al., 1992). It remains to 
be seen whether the ~r-exon-dependent  reduction of neurite 
outgrowth is related to the oligomannosidic glycan-depen- 
dent interaction between L1 and NCAM. 
Immunoglobulin-like domain five has been proposed to 
carry the unusual polysialic acid characteristic of the so- 
called embryonic form of NCAM  (Santoni et ai.,  1988). 
Yang et al. (1992) and Zhang et al. (1992) suggested that L1 
is modulated in its functions by this polysialic acid. Their 
data support the view that homophilic interaction between 
cell surfaces (trans-interaction)  of L1 is modulated by poly- 
siaiic acid rather than the heterophilic interaction within the 
same cell surface (cis-interaction).  Since the hydrated vol- 
ume of NCAM containing polysialic acid is approximately 
three times as large as that of the polypeptide without it 
(Rutishauser and Landmesser, 1991), it is possible, however, 
that polysialic acid would also influence the cis-binding  of 
L1 to NCAM for steric reasons. It is therefore conceivable 
that by modulating the interaction between L1 and NCAM, 
polysialic acid may modify neurite outgrowth (Doherty et 
al.,  1990). 
Mannosidic glycans have been implicated in several recog- 
nition and adhesion processes. They play a role in the bind- 
ing of type I fimbriated bacteria to enterocytes of the intes- 
tine, a prerequisite for infections caused by bacteria (Lis and 
Sharon, 1991). The binding and uptake of these bacteria by 
granulocytes occurs by a process called lectinophagocytosis 
and is initiated by the attachment of bacteria to mannosidic 
glycans  carried  by  the  leucocyte  adhesion  molecule 
CDll/CD18, an integrin (Gbarah et al., 1991). These oligo- 
mannosidic glycan-dependent ligand-receptor associations 
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that these glycans may also be involved in cis-interactions be- 
tween the ix- and/3-integrin subunits as in the interaction be- 
tween L1 and NCAM. The association of the subunits of hu- 
man chorionic gonadotropin is mediated by oligomannosidic 
glycans (Blithe,  1990;  Ji and Ji,  1990).  Another candidate 
for a heterodimeric cis-interaction is thyroglobulin,  which 
carries oligomannosidic glycans (Arima et al.,  1972).  The 
adhesion  molecule  on  glia  AMOG,  the  /32  subunit  of 
Na+/K  + ATPase (Gloor et al.,  1990) which carries 30% of 
its molecular weight predominantly as oligomannosidic gly- 
cans (Fahrig et al.,  1990), can associate with the o~-subunit 
to form a catalytically  active enzyme  (Schmalzing  et al., 
1992). It will be interesting to determine whether this associ- 
ation is also mediated by oligomannosidic glycans. 
A  complex network of interacting  molecules can be cre- 
ated through the binding of carbohydrate  ligands carried by 
different glycolipids or glycoproteins to different  carbohy- 
drate  receptors  (Feizi  and Childs,  1987).  Since adhesion 
molecules expressing oligomannosidic glycans,  such as L1, 
MAG (Fahrig et al., 1990), AMOG (Antonicek et al., 1987; 
Kiicherer et al., 1987), P0 (Bollensen and Schachner,  1987), 
and the integrins (Gbarah et al., 1991; Pesheva et al., 1987) 
are endowed with different functional properties, their inter- 
changeable interactions with NCAM may result in spatially 
and temporally varying effects on cell-cell and cell-extra- 
cellular matrix interactions. 
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